The Association of Serum Iron-Binding Proteins and the Antioxidant Parameter Levels in Age-Related Macular Degeneration

References

• Dunaief J. Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. Invest Ophtalmol Vis Sci. 2006;47:4660–64.
   PubMed Web of Science ®Google Scholar
• Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411–31.
   PubMed Web of Science ®Google Scholar
• Chevion M. A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. Free Radic Biol Med. 1988;5:27–37.
   PubMed Web of Science ®Google Scholar
• Burdo JR, Connor JR. Brain iron uptake and homeostatic mechanisms: an overview. Biometals. 2003;16:63–75.
   PubMed Web of Science ®Google Scholar
• Rouault TA. Iron on the brain. Nat Genet. 2001;28:299–300.
   PubMed Web of Science ®Google Scholar
• Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr. 1998;67:972S–977S.
   PubMed Web of Science ®Google Scholar
• Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94:762–73.
   PubMed Web of Science ®Google Scholar
• Mahud DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015;14(2):183–93.
   PubMed Web of Science ®Google Scholar
• Bulvik BE, Berenshtein E, Konijin AM, Grinberg L, Vinokur V, Eliashar R, Chevion M. Ageing is an organ-specific process: changes in homeostasis of iron-redox proteins in rat. Age. 2012;34:693–704.
   PubMedGoogle Scholar
• Age-Related Eye Disease Study Research Group. A randomized, placebocontroled, clinical trial of high-dose supplementation with vitamin C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no.8. Arch Ophthalmol. 2001;119:1417–36.
   PubMed Web of Science ®Google Scholar
• Goldstein S, Michel C, Boors A, Saran M, Czapsky G. A critical re-evaluation of some assay methods for superoxide dismutase activity. Free Radical Biol Med. 1988;4:295–303.
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterisation of glutathione peroxidase. J Lab Clin Med. 1967;70:158–63.
   PubMed Web of Science ®Google Scholar
• Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant staus in premature neonates. Clin Sci. 1993;84:407–12.
   PubMed Web of Science ®Google Scholar
• Goldberg DM, Spooner RJ. Assay of glutathione reductase. In: Bergmeyen HV, Editor. Methods of enzymatic analysis. Weinheim, Germany : Verlag Chemie; 1983. p. 258–65.
   Google Scholar
• Wysokinski D, Danisz K, Pawlowska E, Dorecka M, Romaniuk D, Robasykiewicy J, Szaflik M, Szaflik J, Blasiak J, Szaflik JP. Transferin receptor levels and polymorphism of its gene in age-related macular degeneration. Acta Biochim Pol. 2015;62(2):177–84.
   PubMed Web of Science ®Google Scholar
• Plestina-Borjan I, Katusic D, Medvidovic-Grubisic M, Supe-Domic D, Bucan K, Tandara L, Rogosic V. Association of age-related macular degeneration with erythrocyte antioxidant enzymes activity and serum total antioxidant status. Oxid Med Cell Longev. 2015;2015:804054. doi:10.1155/2015/804054.
   PubMed Web of Science ®Google Scholar
• Ii H O, Choi EY, Park JS, Lee CH. Association of serum ferritin and kidney function with age/related macular degeneration in the general population. Plos One. 2016;11(4):eo153624.
   Web of Science ®Google Scholar
• Behndig A, Karlsson K, Johansson BO, Brännström T, Marklund SL. Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2293–96.
   PubMed Web of Science ®Google Scholar
• Imamura Y, Noda S, Hashizume K, Shinoda K, Yamaguchi M, Uchiyama S, Schimizu T, Mizushima Y, ShirasawaT, Tsubota K. Drusen, choroidal neovascularization and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A. 2006;103:11282–87.
   PubMed Web of Science ®Google Scholar
• Ćujić D, Stefanovska I, Golubović S. Serum ferritin in healthy women and breast cancer patients. J Med Biochem. 2010;30(1):33–37.
   Web of Science ®Google Scholar
• Elliot SJ, Catanuto P, Espinosa–Heidmann DG, Fernandez P, Hernandez E, Saloupis P, Korach K, karl M, Cousins SW. Estrogen receptor β protects against in vivo injury in RPE cells. Exp Eye Res. 2010;90(1):10–6.
   PubMed Web of Science ®Google Scholar
• Haan MN, Klein R, Klein BE, Deng Y, Blythe LK, Seddon JM, Musch DC, Kuller LH, Hyman LG, Wallace RB. Hormone therapy and age-related macular degeneration: the Women’s Health Initiative Sight Exam Study. Arch Ophthalmol. 2006;124(7):988–92.
   PubMedGoogle Scholar
• Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol. 1997;25(Suppl 1):S13–5.
   PubMedGoogle Scholar
• Cascio C, Deidda I, Russo D, Guarneri P. The estrogenic retina: the potential contribution to healthy aging and age-related neurodegenerative diseases of the retina. Steroids. 2015;103:31–41.
   PubMed Web of Science ®Google Scholar
• Cousins SW, Marin‐Castano ME, Espinosa‐Heidmann DG, Alexandridou A, Striker L, Elliot S. Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice. Invest Ophthalmol Vis Sci. 2003;44:1221–29.
   PubMed Web of Science ®Google Scholar
• Sergejeva O, Botov R, Liutkevičienė R, Kriaučiūnienė L. Genetic factors associated with the development of age-related macular degeneration. Medicina (Kaunas). 2016;52(2):79–88. doi:10.1016/j.medici.2016.02.004
   PubMed Web of Science ®Google Scholar
• Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal. 2002;16:237–45.
   PubMed Web of Science ®Google Scholar
• Doulias PT, Vlachou C, Boudouri C, Kanavaros P, Siamopoulos KC, Galaris D. Flow cytometric estimation of ‘labile iron pool’ in human white blood cells reveals a positive association with ageing. Free Radic Res. 2008;42:253–59.
   PubMed Web of Science ®Google Scholar
• Fleming DJ, Tucker KL, Jacques PF, Dallal GE, Wilson PW, Wood RJ. Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort. Am J Clin Nutr. 2002;76:1375–84.
   PubMed Web of Science ®Google Scholar
• Killilea DW, Atamna H, Liao C, Ames BN. Iron accumulation during cellular senescence in human fibroblasts in vitro. Antioxid Redox Signal. 2003;5:507–16.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease – an overview. Meth Enzymol. 1990;186:1–85.
   PubMed Web of Science ®Google Scholar
• Ngn M. Role of hydrogen peroxide in the aetiology of Alzheimer’s disease – implications for treatment. Drugs & Aging. 2004;21:81–100.
   PubMed Web of Science ®Google Scholar
• Song D, Dunaief JL. Retinal iron homeostasis in health and disease. Front Aging Neurosci. 2013;5:24. doi:10.3389/fnagi.2013.00024.
   PubMed Web of Science ®Google Scholar
• Thomson AM, Rogers JT, Leedman PJ. Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. Int J Biochem Cell Biol. 1993;31(10):1139–52.
   Web of Science ®Google Scholar
• Bu W, Liu R, Cheung-Lau JC, Dmochowski IJ, Loll PJ, Eckenhoff RG. Ferritin couples iron and fatty acid metabolism. The FASEB J. 2012;26:2394–400.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Olin KL, Feuer WJ, Hjelmeland L, Keen CL, Morse LS. Low glutathione reductase and peroxidase activity in age-related macular degeneration. Br J Ophthalmol. 1994;78:791–94.
   PubMed Web of Science ®Google Scholar
• Evans J. Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye (Lond). 2008;22:751–60.
   PubMed Web of Science ®Google Scholar
• Čolak E, Majkić-Singh N, Žorić L, Radosavljević A, Kosanović-Jaković N. The impact of inflammation to the antioxidant defense parameters in AMD patients. Aging Clin Exp Res. 2013;24(16):588–94.
   Google Scholar
• Čolak E, Kosanović-Jaković N, Žorić L, Radosavljević A, Stanković S, Majkić-Singh N. The association of lipoprotein parameters and C-reactive protein in patients with age-related macular degeneration. Ophthalmic Res. 2011;46:125–32.
   PubMed Web of Science ®Google Scholar
• Čolak E, Majkić-Singh N, Žorić L, Radosavljević A, Kosanović-Jaković N. The role of CRP and inflammation in the pathogenesis of age-related macular degeneration. Biochem Med (Zagreb). 2012;22(1):39–48.
   PubMed Web of Science ®Google Scholar
• Čolak E, Ignjatović S, Radosavljević A, Žorić L. The association of enzymatic and non-enzymatic antioxidant defense parameters with inflammatory markers in patients with exudative form of age-related macular degeneration. J Clin Biochem Nutr. 2017 Mar;60(2):100–07.
   PubMed Web of Science ®Google Scholar